Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KCT0003220Phase 4Completed
Phase 4 trial of dexmedetomidine in decompensated cirrhosis, sponsored by Asan Medical Center. Primary endpoint: Postoperative renal function. Started Jul 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on KCT0003220.